12 HCP Email Marketing Best Practices

A substantial 65% of HCPs have identified email as their preferred mode of communication, with most HCPs habitually checking their emails across various devices throughout the day. 

The Value of Patient Perspectives in Answering Key Business Questions

Health Union’s recently-evolved research programs help clients better understand both holistic and condition-specific patient journeys.

How to Market Medical Supplies and Equipment (the Right Way)

Looking to market medical supplies & equipment to HCPs? It’s not as complicated as you’d think. Here’s everything you need to know.

7 Healthcare Programmatic Advertising Best Practices

Whether you’re looking to boost patient engagement, increase provider awareness, or maximize your ROI, Health Union has the insights to take your programmatic advertising to the next level.

Medical Device Advertising Regulations: What to Know

Right now, medical device advertising doesn’t come with a ton of red tape — at least not as much as you’d think,

Healthcare Geofencing: The What & Why

Healthcare geofencing campaigns use programmatic technology that leverages GPS signals from HCPs’ devices and delivers ads based on this data.

Patient Leader Perspectives: Co-Design with ‘Patients from the Start’

These two accomplished patient leaders combined their experiences and perspectives to explain how industry can integrate “patients from the start.”

Understanding Rare Conditions: The Impact on Relationships

Findings from Health Union’s surveys of its rare condition communities show one’s relationships and social life can take significant hits.

NPI Targeting: 3 Reasons It’s a Healthcare Advertiser’s Best Friend

A 1:1 relationship with HCPs isn’t a guarantee. NPI targeting significantly increases the likelihood that happens.

Maximizing Consumer Engagement with People Living with Rare Disease

Understanding the difficulties people with rare conditions often face can help set the table for the engagement challenges pharma marketers typically face.